How viable is point-of-care MRI?
Wednesday, November 29 | 3:40 p.m.-3:50 p.m. | W7-SSNR12-5 | Room E353B Is point-of-care MRI a viable tool for critically ill patients? The answer is yes, according to research to be presented Wednesday afternoon.Point-of-care MRI is a promising tool for treating critically ill patients who can't be transported to the imaging suite, wrote a team led by presenter Brian Gerard Yep, MD, of the University of California, Irvine (UCI) Medical Center in Orange, CA."This technology is promising in critically ill patients too unstable to transport where early MRI access is critical for improved survival and better patient outcome...
Source: AuntMinnie.com Headlines - November 16, 2023 Category: Radiology Authors: Kate Madden Yee Tags: 2023 MRI Preview Source Type: news
Rapid AI gets FDA nod for Rapid SDH
RapidAI has received 501(k) clearance from the U.S. Food and Drug Administration (FDA) for Rapid SDH, an AI-powered module for detecting suspected hemispheric acute and chronic subdural hematoma.With the Rapid mobile app, Rapid SDH automatically sends results to the entire trauma team across the hospital system or treatment network.The company highlighted the following characteristics of Rapid SDH:Features hemispheric subdural hematomas, intracerebral brain hemorrhage, and hyperdensity for faster and complete patient assessment.Positive predictive value of 99% (sensitivity 93%, specificity 99%) for suspected acute and chro...
Source: AuntMinnie.com Headlines - November 9, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Father claims AstraZeneca's Covid vaccine is 'defective' as the drugs giant faces a landmark High Court battle over the accusations
Bringing the court action is IT engineer Jamie Scott, who suffered a brain haemorrhage the day after his first AstraZeneca jab, leaving him with permanent brain damage. (Source: the Mail online | Health)
Source: the Mail online | Health - November 9, 2023 Category: Consumer Health News Source Type: news
Hemorrhagic stroke caused by xylometazoline poisoning - Bana ś BP, Brzeźniakiewicz-Janus K, Majdanik S, Parafiniuk M, Łużny S, Stachowicz A, Janus T.
We present the fatal case of a 40 year-old-w... (Source: SafetyLit)
Source: SafetyLit - November 6, 2023 Category: International Medicine & Public Health Tags: Poisoning Source Type: news
Risk of cerebral hemorrhage in mild traumatic brain injury and antithrombotic treatment - Mart ínez-Rivas JJ, Rodríguez-Lucas F, Planells G, Corrales D, Cocho D.
INTRODUCTION: The observation time in mild traumatic brain injury (mTBI) is controversial. Our aim was to assess the risk of neurological complications in mTBI with and without antithrombotic treatment. METHOD: We retrospectively evaluated patients... (Source: SafetyLit)
Source: SafetyLit - October 30, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
What Are Potential Complications of a Forceps Delivery?
Discussion
The main outcome of any delivery is to have a healthy mother and healthy child. For millinea, mothers delivered babies with the help of their mothers and learned women without the benefits of potential instrumented interventions when complications arose, and today they are options for some deliveries. Instrumented delivery techniques have markedly decreased maternal and neonatal morbidity and mortality. Instrument delivery techniques in the second stage of labor includes forceps (begun in the 1600s), vacuum delivery (mainly use began in 1950s) and second stage cesarean section (cesarean section being first used ...
Source: PediatricEducation.org - October 23, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Saving lives, improving mothers ’ care: lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2019-21
This report, the tenth MBRRACE-UK annual report of the Confidential Enquiry into Maternal Deaths and Morbidity, includes surveillance data on women who died during or up to one year after pregnancy between 2019 and 2021 in the UK. In addition, it also includes confidential enquiries into the care of women who died between 2019 and 2021 in the UK and Ireland from obstetric haemorrhage, amniotic fluid embolism, anaesthetic causes, infection, general medical and surgical disorders and epilepsy and stroke. The report also includes a Morbidity Confidential Enquiry into the care of women with morbidity following repeat caesarean...
Source: The Kings Fund - Health Management Specialist Collection - October 17, 2023 Category: Health Management Authors: The King ' s Fund Library Tags: Patient safety Source Type: news
6 Stories Show the Human Toll of Poland ’ s Strict Abortion Laws
This project was supported by the Pulitzer Center
[time-brightcove not-tgx=”true”]
Krzysztof Sowinski has cried every day since his wife Marta, who was five months pregnant, died of sepsis in 2022; he believes doctors put Marta’s life in danger by not giving them the option to terminate the pregnancy while the fetus’ heart was still beating. Janusz Kucharski also lost his partner Justyna to sepsis in the fifth month of a pregnancy. She left behind two boys.
It is likely, reproductive-rights advocates say, that these women would be alive if not for Poland’s increasingly restrictive abort...
Source: TIME: Health - October 13, 2023 Category: Consumer Health News Authors: Anna Pamula Tags: Uncategorized abortion Source Type: news
Ultrahigh-resolution CTA bests conventional for aneurysm detection
Ultrahigh-resolution CT angiography {CTA bests conventional for the detection of ruptured intracranial aneurysms, offering higher sensitivity, improved image quality, and reduced radiation dose, according to a study published October 9 in Academic Radiology.The findings could translate into better patient care, wrote a team led by Marius Frenzel of Johannes Gutenberg University, in Mainz, Germany."The 'time is brain' paradigm emphasizes the importance of timely and accurate diagnostics in the case of hemorrhagic stroke," the group noted. "If a ruptured aneurysm is missed in primary CTA imaging and diagnosed later on additi...
Source: AuntMinnie.com Headlines - October 10, 2023 Category: Radiology Authors: Kate Madden Yee Tags: CT Source Type: news
AHA Reviews Impact of Aggressive LDL Lowering on the Brain AHA Reviews Impact of Aggressive LDL Lowering on the Brain
The preponderance of evidence does not support the conclusion that aggressive cholesterol-lowering is associated with cognitive impairment or hemorrhagic stroke, a new statement concludes.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - September 18, 2023 Category: Primary Care Tags: Cardiology News Source Type: news
Blood Transfusions Linked to Intracerebral Hemorrhage Risk Blood Transfusions Linked to Intracerebral Hemorrhage Risk
An exploratory analysis suggests a transfusion-transmissible agent associated with brain amyloidosis may be associated with some types of spontaneous intracerebral hemorrhage.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - September 13, 2023 Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news
In Rare Cases, Blood Transfusion Might Cause Brain Hemorrhage
TUESDAY, Sept. 12, 2023 -- It’s possible that the cause of spontaneous, recurring brain hemorrhages can be passed through blood transfusion, researchers say.
The likelihood of this happening is very slim, however.
Still,“blood... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 12, 2023 Category: General Medicine Source Type: news
Roche and Alnylam report positive topline results from Phase 2 study KARDIA-1 of zilebesiran, an investigational RNAi therapeutic in development to treat hypertension in patients at high risk of cardiovascular disease
Zilebesiran met primary endpoint demonstrating greater than 15 mmHg reduction of systolic blood pressure at three months of treatment compared to placeboStudy met key secondary endpoints showing consistent and sustained reductions of systolic blood pressure at six monthsZilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertensionFull study results to be presented at an upcoming scientific conferenceBasel, 7 September 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Alnylam announced today that the Phase 2 study KARDIA-1 of zilebesiran, an investigational RNAi the...
Source: Roche Media News - September 7, 2023 Category: Pharmaceuticals Source Type: news
Roche and Alnylam report positive topline results from Phase 2 study KARDIA-1 of zilebesiran, an investigational RNAi therapeutic in development to treat hypertension in patients at high risk of cardiovascular disease
Zilebesiran met primary endpoint demonstrating greater than 15 mmHg reduction of systolic blood pressure at three months of treatment compared to placeboStudy met key secondary endpoints showing consistent and sustained reductions of systolic blood pressure at six monthsZilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertensionFull study results to be presented at an upcoming scientific conferenceBasel, 7 September 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Alnylam announced today that the Phase 2 study KARDIA-1 of zilebesiran, an investigational RNAi the...
Source: Roche Investor Update - September 7, 2023 Category: Pharmaceuticals Source Type: news
